paxilline has been researched along with Cancer of Liver in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (50.00) | 29.6817 |
2010's | 8 (36.36) | 24.3611 |
2020's | 3 (13.64) | 2.80 |
Authors | Studies |
---|---|
Bai, Y; Cao, Z; Chen, X; Cheng, W; Cui, H; Guan, XY; Huang, L; Liu, M; Liu, S; Ma, L; Ma, NF; Mo, Y; Qi, L; Wang, G; Zhang, X | 1 |
Liu, L; Liu, T; Wang, Y; Xu, H; Yang, T; Zhou, J | 1 |
Chen, S; Hu, J; Ma, Y; Wang, J; Wang, X; Wen, L; Wu, T; Yue, T; Zhang, J; Zhang, X; Zhu, J | 1 |
Liu, XN; Pan, W; Sun, SH; Tao, QF; Wang, F; Wang, TT; Yuan, JH; Zhou, WP | 1 |
Cheng, CC; Hu, CT; Pan, SM; Wu, JR; Wu, WS | 1 |
Cai, QQ; Chen, Q; Deng, NH; Dong, YW; Jin, YT; Li, C; Qi, B; Wang, R; Wu, XZ | 1 |
Cao, L; Zhang, L; Zhang, Y; Zhao, X | 1 |
Deng, Z; Liao, Y; Shen, J; Shen, W; Wu, W; Xu, Z; Yuan, Q; Zhang, W; Zhang, Y; Zheng, L; Zhu, L | 1 |
Aalbers, RI; de Heer, P; Koudijs, MM; Kuppen, PJ; Morreau, J; Putter, H; Tollenaar, RA; van de Velde, CJ; van de Water, B | 1 |
Chen, ZN; Jiang, JL; Tang, J; Wu, YM; Yang, XM; Zhao, P | 1 |
Chen, ZN; Jiang, JL; Tang, J; Wu, YM; Zhao, P | 3 |
Bai, XM; Jiang, H; Leng, J; Liu, NB; Lou, KX; Ma, J; Peng, T; Zhang, H; Zhang, L; Zhang, W | 1 |
Chan, LK; Ching, YP; Leung, TH; Ng, IO; Yam, JW | 1 |
Elliott, VA; Evers, BM; Gulhati, P; Lee, EY; Morris, AJ; Mustain, WC; O'Connor, K; Rychahou, PG; Sunkara, M; Weiss, HL; Zaytseva, YY | 1 |
Alisi, A; Arciello, M; Balsano, C; Conti, B; Missale, G; Petrini, S | 1 |
Enns, A; Fisch, KM; Gassmann, P; Haier, J; Nicolson, GL; von Sengbusch, A | 1 |
Li, HG; Li, HH; Shen, XM; Xie, DR; Zeng, H; Zeng, YJ | 1 |
Ching, YP; Jin, DY; Lee, MF; Leong, VY; Ng, IO; Xu, HT | 1 |
Akedo, H; Ayaki, M; Imamura, F; Mukai, M | 1 |
Ayaki, M; Ishiguro, S; Kameyama, M; Komatsu, K; Miyoshi, J; Mukai, M; Murata, K; Nakamura, H; Tatsuta, M | 1 |
22 other study(ies) available for paxilline and Cancer of Liver
Article | Year |
---|---|
CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3.
Topics: Animals; Autophagy; Autophagy-Related Protein 5; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; DNA Helicases; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Neoplasm Metastasis; Paxillin; RNA, Small Interfering; Transcription Factors; Transcription, Genetic | 2021 |
LncRNA FIRRE promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the expression of PXN through interacting with MBNL3.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Paxillin; RNA-Binding Proteins; RNA, Long Noncoding; Up-Regulation | 2022 |
Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway.
Topics: Aged; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colon; Colorectal Neoplasms; Desmosomes; Disease Progression; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Female; Follow-Up Studies; Humans; Intestinal Mucosa; Liver; Liver Neoplasms; Lymphatic Metastasis; Male; MAP Kinase Signaling System; Mice; Microscopy, Electron, Transmission; Microvilli; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paxillin; Retrospective Studies; Xenograft Model Antitumor Assays | 2020 |
The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1.
Topics: 3' Untranslated Regions; Alternative Splicing; Animals; Argonaute Proteins; Binding Sites; Carcinoma, Hepatocellular; Carrier Proteins; Cell Proliferation; Exons; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hep G2 Cells; High-Throughput Nucleotide Sequencing; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Nude; MicroRNAs; Nanog Homeobox Protein; Octamer Transcription Factor-3; Paxillin; Protein Binding; RNA Interference; RNA-Binding Proteins; RNA, Long Noncoding; SOXB1 Transcription Factors; Time Factors; Transfection; Tumor Burden; Up-Regulation | 2017 |
PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2.
Topics: Animals; Carcinoma, Hepatocellular; Cell Movement; Concanavalin A; Endocytosis; Extracellular Signal-Regulated MAP Kinases; Hep G2 Cells; Hepatocyte Growth Factor; Humans; Indoles; Isoenzymes; Liver Neoplasms; Maleimides; Mice; Mice, SCID; Mitogens; Paxillin; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-met; rac GTP-Binding Proteins; RNA Interference; RNA, Small Interfering; Signal Transduction; Transplantation, Heterologous | 2013 |
Sulfatide interacts with and activates integrin αVβ3 in human hepatocellular carcinoma cells.
Topics: Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Neoplastic; Humans; Integrin alphaVbeta3; Liver Neoplasms; Paxillin; Phosphorylation; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; src-Family Kinases; Sulfoglycosphingolipids; Tyrosine | 2016 |
A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Bibenzyls; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Chalcone; Cytoskeleton; Focal Adhesions; Hep G2 Cells; Humans; Isatin; Liver Neoplasms; Molecular Targeted Therapy; Oncogene Proteins; Paxillin; Protein Multimerization; Protein Structure, Quaternary; Tubulin; Vacuoles; Wnt Signaling Pathway | 2016 |
Immediate early response protein 2 regulates hepatocellular carcinoma cell adhesion and motility via integrin β1-mediated signaling pathway.
Topics: Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Extracellular Matrix; Fibronectins; Focal Adhesion Kinase 1; Gene Knockdown Techniques; Humans; Immediate-Early Proteins; Integrin beta1; Liver Neoplasms; Paxillin; Signal Transduction; Trans-Activators | 2017 |
Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation.
Topics: Adolescent; Adult; Biomarkers, Tumor; Child; Child, Preschool; Colorectal Neoplasms; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunohistochemistry; Infant; Infant, Newborn; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paxillin; Prognosis; src-Family Kinases | 2008 |
Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways.
Topics: Basigin; Calcium; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytoskeleton; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Gene Silencing; Humans; Integrin alpha3beta1; Liver Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Paxillin; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors | 2008 |
Betaig-h3 interacts with alpha3beta1 integrin to promote adhesion and migration of human hepatoma cells.
Topics: Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cytoskeleton; Extracellular Matrix Proteins; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Integrin alpha3beta1; Liver Neoplasms; Neoplasm Invasiveness; Paxillin; Transfection; Transforming Growth Factor beta | 2009 |
Enhanced expression of Hab18g/CD147 and activation of integrin pathway in HCC cells under 3-D co-culture conditions.
Topics: Adult; Basigin; Carcinoma, Hepatocellular; Cell Adhesion; Cell Culture Techniques; Fibroblasts; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrins; Liver Neoplasms; Male; Matrix Metalloproteinases; Paxillin; Tumor Cells, Cultured | 2009 |
Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
Topics: Blotting, Western; Carcinoma, Hepatocellular; Cell Adhesion; Cell Movement; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Dinoprostone; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression; Humans; Liver Neoplasms; Neoplasm Invasiveness; Paxillin; Phosphorylation; RNA Interference; Signal Transduction | 2009 |
Morphological changes and molecular expressions of hepatocellular carcinoma cells in three-dimensional culture model.
Topics: Basement Membrane; Basigin; Blotting, Western; Carcinoma, Hepatocellular; Cell Adhesion; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Cytoskeleton; Extracellular Matrix; Fluorescent Antibody Technique; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression; Gene Expression Profiling; Humans; Liver Neoplasms; Matrix Metalloproteinases; Microscopy, Confocal; Neoplasm Invasiveness; Paxillin | 2009 |
Deleted in liver cancer 2 suppresses cell growth via the regulation of the Raf-1-ERK1/2-p70S6K signalling pathway.
Topics: Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; GTPase-Activating Proteins; Hep G2 Cells; Humans; Liver Neoplasms; Paxillin; Proto-Oncogene Proteins c-raf; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; RNA, Small Interfering; Signal Transduction; Transfection; Tumor Suppressor Proteins | 2010 |
Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.
Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Down-Regulation; Fatty Acid Synthases; Focal Adhesion Kinase 1; Gene Knockdown Techniques; Humans; Hyaluronan Receptors; Lipogenesis; Liver Neoplasms; Male; Mice; Mice, Nude; Oncogene Protein v-akt; Paxillin; Proto-Oncogene Proteins c-met; Signal Transduction; Xenograft Model Antitumor Assays | 2012 |
Focal adhesion kinase (FAK) mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)-infected cells.
Topics: Actinin; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Focal Adhesion Protein-Tyrosine Kinases; Hepacivirus; Hepatic Stellate Cells; Hepatitis C; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Paxillin; Tumor Necrosis Factor-alpha | 2012 |
Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids.
Topics: Animals; Carcinoma; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Collagen; Colon; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Endothelium, Vascular; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunoprecipitation; Liver; Liver Neoplasms; Male; Microcirculation; Microscopy, Fluorescence; Neoplasm Metastasis; Neoplasms; Oligonucleotides; Paxillin; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Time Factors; Transfection; Tyrosine | 2005 |
Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma.
Topics: Adult; Aged; Antigens, CD; Basigin; Carcinoma, Hepatocellular; Cytoskeletal Proteins; Female; Humans; Liver Neoplasms; Male; Membrane Glycoproteins; Middle Aged; Paxillin; Phosphoproteins; Proteoglycans; Syndecan-1; Syndecans | 2005 |
P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; Neoplasm Metastasis; p21-Activated Kinases; Paxillin; Phosphorylation; Protein Serine-Threonine Kinases | 2007 |
Y-27632, an inhibitor of rho-associated protein kinase, suppresses tumor cell invasion via regulation of focal adhesion and focal adhesion kinase.
Topics: Actins; Amides; Animals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Movement; Cytoskeletal Proteins; Drug Interactions; Enzyme Inhibitors; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Lysophospholipids; Neoplasm Invasiveness; Paxillin; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyridines; Rats; rho-Associated Kinases; Tumor Cells, Cultured; Tyrosine | 2000 |
Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas.
Topics: Adenocarcinoma; Blotting, Western; Colorectal Neoplasms; Cytoskeletal Proteins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunohistochemistry; Liver Neoplasms; Paxillin; Phosphoproteins; Protein-Tyrosine Kinases; Talin; Vinculin | 2001 |